Search All News
By participating in one of the world’s largest genetic studies, New Yorkers will help bring precision medicine to their communities, Columbia’s David Goldstein explains.
Among teens treated in an emergency department for drug-related symptoms, nearly 20% who used Spice, K2, or other synthetic cannabinoids experienced seizures.
- May 22, 2019
A new study of a single-celled organism with 16,000 tiny chromosomes may shed light on a recently discovered feature of the human genome.
- May 15, 2019
A study shows that one in 7 kidney donor-recipient pairs may have a type of genetic incompatibility that leads to organ rejection.
- May 14, 2019
A new study suggests that providers make the same number of wrong-patient errors regardless of the number of electronic patient records they could have open at a time.
- May 10, 2019
Columbia engineers and surgeons show that new salvage methods can recondition severely damaged lungs to meet transplantation criteria and could make more lungs available for patients.
- May 7, 2019
A new study suggests that depression and GI trouble sometimes spring from the same source—low serotonin—and identifies a potential treatment that could ease both conditions.
- May 2, 2019
Four researchers at VP&S have been named 2019 Schaefer Research Scholars and will pursue new ideas in cancer metastasis, neurodegenerative disease, and compulsive behavior.
- April 9, 2019
A new study from Columbia pediatricians found that new mothers are more receptive to educational materials that contain facts, not criticism, about sugary drinks.
- April 1, 2019
Columbia researchers may have uncovered a new way to prevent, and possibly reverse, the liver's deterioration during fatty liver disease, which affects one in four Americans.
- March 25, 2019
3D imaging is revealing how friendly bacteria communicate with their hosts to take up residence in the gut.